Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.
At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.
Study Type
OBSERVATIONAL
Enrollment
250,000
University Hospital Zurich
Zurich, Switzerland
Percentage of transfusions per participant
Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions
Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Percentage of transfusion of any blood product per participant
Count of any blood products per case, QM Data
Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Cost of any blood product per participant
costs per case
Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
Survey of Patient Blood Management System
clinical, financial,and administrative data of all participants will be reviewed on the focus on transfusions
Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.